Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans
Recruiting · NCT07576595 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Smoking cessation multilevel Intervention
What this trial is about
This study aims to reduce disparities and the burden of lung cancer among African American smokers by supporting a Multiple-level intervention integrating lung cancer screening and smoking cessation (MILS), followed the NIH DEIA strategies using multilevel interventions that impact determinants of health and address health disparities at appropriate time points across the life course.
Who can take part
Age range
50 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- African American
- 20+ pack years of smoking
- eligible for or received LDCT screening
- current smoker
- English speaking
Exclusion criteria
- N/A
Where it is running
2 locations listed across 1 US state.
- LSUHSC School of Public Health - New Orleans, Louisiana, United States
- University Medical Center - New Orleans, Louisiana, United States